Shopping Cart
- Remove All
Your shopping cart is currently empty
BI‑3231 is a selective and potent inhibitor of hydroxysteroid 17ß-dehydrogenase 13 HSD17B13, inhibiting hHSD17B13 and mHSD17B13.BI-3231 can be used for the study of alcohol-associated liver injury, fibrosis and cirrhosis.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $66 | In Stock | |
| 5 mg | $158 | In Stock | |
| 10 mg | $248 | In Stock | |
| 25 mg | $397 | In Stock | |
| 50 mg | $569 | In Stock | |
| 100 mg | $786 | In Stock | |
| 200 mg | $1,090 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $176 | In Stock |
| Description | BI‑3231 is a selective and potent inhibitor of hydroxysteroid 17ß-dehydrogenase 13 HSD17B13, inhibiting hHSD17B13 and mHSD17B13.BI-3231 can be used for the study of alcohol-associated liver injury, fibrosis and cirrhosis. |
| In vitro | In vitro Pharmacology, B1-3231 demonstrates a good metabolic clearance rate.[1]. |
| In vivo | Plasma and liver pharmacokinetics in mice after single oral administration of 50 μmol/kg 45 (BI-3231) showing extensive compound distribution and retention in the liver compared to plasmav[1]. |
| Molecular Weight | 380.37 |
| Formula | C16H14F2N4O3S |
| Cas No. | 2894848-07-6 |
| Smiles | O=C1C(=CN(C(=O)N1CC)CC2=NN=C(S2)C=3C=CC(F)=C(O)C3F)C |
| Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (262.90 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (10.52 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.